Champions Oncology, Inc. (CSBR)
NASDAQ · Healthcare
Champions Oncology, Inc. Shareholder Equity 2018–2025
Champions Oncology, Inc. annual shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Champions Oncology, Inc. shareholder equity as of April 30, 2025: 3.8M, a 298.21% decrease year-over-year.
- Champions Oncology, Inc. shareholder equity for 2025 were 3.8M, a 298.21% decrease from 2024.
- Champions Oncology, Inc. shareholder equity for 2024 were -1.9M, a 141.05% decrease from 2023.
- Champions Oncology, Inc. shareholder equity for 2023 were 4.6M, a 49.03% decrease from 2022.
- Champions Oncology, Inc. shareholder equity for 2022 were 9.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Champions Oncology, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $4 |
| 2024 | $-2 |
| 2023 | $5 |
| 2022 | $9 |
| 2021 | $7 |
| 2020 | $5 |
| 2019 | $2 |
| 2018 | $0 |
Champions Oncology, Inc. Shareholder Equity — FAQ
Champions Oncology, Inc. (CSBR) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CSBR's shareholder equity history?
The chart and table above show Champions Oncology, Inc.'s shareholder equity by year and by quarter, including the growth rate.